Synthesis, structure and in vitro biological activity of new hydroxy-naphthoquinonato triorganotin compounds

Synthesis and Reactivity in Inorganic, Metal-Organic and Nano-Metal Chemistry

Volumn 36, Issue 10, 2006, Pages 765-775

  Valla, Vasiliki ^a   Bakola Christianopoulou, Maria ^a   Akrivos, Pericles ^a   Kojic, Vesna ^b   Bogdanovic, Gordana ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Institute of Oncology   (Serbia)

Author keywords

Hydroxy naphthoquinones; SRB assay; Triorganotins

Indexed keywords

EID: 33845286554     PISSN: 15533174     EISSN: 15533182     Source Type: Journal    
DOI: 10.1080/15533170601028298     Document Type: Article

References (45)

1. O'Brien, P. J. Molecular mechanisms of quinone cytotoxicity. Chem. Biol. Interact. 1991, 80, 1-41.
2. Yee, S. B.; Pritsos, C. A. Comparison of oxygen radical generation from the reductive activation of doxorubicin, streptonigrin, and menadione by xanthine oxidase and xanthine dehydrogenase. Arch. Biochem. Biophys. 1997, 347(2), 235-241.
3. Martin, R. B. 2-amino-1,4-naphthoquinone as a model compound for actinomycins. Acta Biochim. Biophys, 1964, 91, 642-644.
4. Moore, H. W.; Czerniak, R. Naturally occurring quinones as potential bioreductive alkylating agents. Med. Res. Rev. 1981, 1 (3), 249-280.
5. Papageorgiou, V. P.; Assimopoulou, A. N.; Couladouros, E. A.; Hepworth, D.; Nicolaou, K. C. The chemistry and biology of alkannin, shikonin, and related naphthazarin natural products. Angew Chem. Int. Ed. 1999, 38 (3), 270-301.
6. Hatzigrigoriou, E.; Papadopoulou, M. V; Shields, D. 2-Alkylsulfonyloxy-3- hydroxy-1,4-naphthoquinones: A novel class of radio- and chemosensitizers of V79 cells. Oncol. Res. 1993, 5, 29-36.
7. Asche, C. Antitumour quinones. Mini Rev. Med. Chem. 2005, 5 (5), 449-467.
8. Inbaraj, J. J.; Chignell, C. F. Cytotoxic action of juglone and plumbagin: a mechanistic study using HaCaT keratinocytes. Chem. Res. Toxicol. 2004, 17, 55-62.
9. Paulsen, M. T; Ljungman, M. The natural toxin juglone causes degradation of p53 and induces rapid H2AX phosphorylation and cell death in human fibroblasts. Toxicol. Appl. Pharmacol. 2005, 209 (1), 1-9.
10. Wang, H.; Mao, Y.; Chen, A. Y. Stimulation of topoisomerase II-mediated DNA damage via a mechanism involving protein thiolation. Biochemistry 2001, 40 (11), 3316-3323.
11. Chao, S. H.; Greenleaf, A. L.; Price, D. H. Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin 1, also directly blocks transcription. Nucleic Acids Res. 2001, 29, 767-773.
12. Varga, Z.; Bene, L.; Pieri, C.; Damjanovich, S.; Gaspar, R. Jr. The effect of juglone on the membrane potential and whole-cell K+ currents of human lymphocytes. Biochem. Biophys. Res. Commun. 1996, 218 (3), 828-832.
13. Habbal, O. A.; Al-Jabri, A. A.; El-Hag, A.H.; Al-Mahrooqi, Z. H.; Al-Hashmi, N. A. In-vitro antimicrobial activity of Lawsonia inermis Linn (henna). A pilot study on the Omani henna. Saudi Med. J. 2005, 26 (1), 69-72.
14. Mikhaeil, B. R.; Badria, F. A.; Maatooq, G. T. Antioxidant and immunomodulatory constituents of henna leaves. Z Naturforsch [C]. 2004, 59 (7-8), 468-476.
15. Salunke-Gawali, S.; Rane, S. Y.; Puranik, V. G; Gugand-Duhayon, C.; Varret, f. Three dimensional hydrogen-bonding network in a copper complex of 2-hydroxy-1,4-naphthoquinone: Structural, spectroscopic and magnetic properties. Polyhedron 2004, 25(16), 2541-2547.
16. Bodini, M. E.; Bravo, P. E.; Aranciba, V. Voltammetric and spectroscopic study of the iron(II) complexes with the semiquinone of 2-hydroxy-1,4- naphthoquinone (lawsone) in aprotic medium. Polyhedron 1994, 13 (3), 497-503.
17. El-Hendawy, A. M. Complexes of lawsone with uranium, molybdenum, ruthenium and osmium, and their use as organic oxidants. Polyhedron 1991, 10 (20-21), 2511-2518.
18. Garge, P.; Padhye, S.; Tuchagues, J. Iron(II) complexes of ortho-functionalized para-naphthoquinones 1. Synthesis, characterization, electronic structure and magnetic properties. Inorg. Chim. Acta. 1989, 157 (2), 239-249.
19. Christianopoulou, M. Synthesis and studies of some bivalent metal chelates of 1,2-dihydroxy-9,10-anthracenedione and 5-hydroxy-1,4- naphthalenedione. Polyhedron 1984, 3 (6), 7-29.
20. Christianopoulou, M.; Ecateriniadou, L.; Sarris, E. Evaluation of the antimicrobial activity of a new series of hydroquinone chelates of some transition metals. Eur. J. Med. Chem. 1986, 21 (5), 385-390.
21. Papageorgiou, V. P.; Christianopoulou, M.; Boutis, L.; Papageorgiou, A.; Tsipis, C. Synthesis and antitumor activity of a novel diplatinum complex of the binucleating naphthazarinato ligand. Inorg. Chim. Acta 1986, 124 (4), 203-206.
22. Bakola-Christianopoulou, M.; krivos, P. D.; Ecateriniadou, L. B.; Sarris, K. On the anti-bacterial activity of non-charged μ-naphthazarinato compounds. Eur. J. Med. Chem. 1988, 23(1), 87-90.
23. Lialiaris, T.; Mourelatos, D.; Boutis, L.; Papageorgiou, A.; Christianopoulou, M.; Papageorgiou, V.; Dozi-Vassiliades, J. Comparative study on cytogenetic effects by diplatinum complexes of the ligands of naphthazarine and squaric acid in human lymphocytes. J. Pharmacol. Exp. Therap. 1989, 257 (1), 368-371.
24. Gielen, M.; Willem, R.; Biesemans, R.; Boulam, M.; Khloufi, A.; Elde Vos, D. Exceptionally high in vitro antitumor activity of substituted triphenyltin benzoates including salicylates against a human mammary tumor, MCF-7, and a colon carcinoma, WiDr. Appl. Organometal. Chem. 1992, 6 (3), 287-291.
25. Gielen, M. Tin-based antitumour drugs. Coord Chem. Rev. 1996, 151, 41-51.
26. Gielen, M.; Biesemans, M.; de Vos, D.; Willem, R. Synthesis, characterization and in vitro antitumor activity of di- and triorganotin derivatives of polyoxa- and biologically relevant carboxylic acids. Inorg. Biochem. 2000, 79, 139-145.
27. Gielen, M. Organotin compounds and their therapeutic potential: A report from the organometallic chemistry department of the free university of Brussels. Appl. Organometal. Chem. 2002, 16, 481-494.
28. Gielen, M.; Biesemans, M.; Willem, R. Organotin compounds: from kinetics to stereochemistry and antitumour activities. Appl. Organometal. Chem. 2005, 19, 440-450.
29. Pellerito, L.; Nagy, L. Organotin(IV)n+ complexes formed with biologically active ligands: equilibrium and structural studies, and some biological aspects. Coord. Chem. Rev. 2002, 224, 111-150.
30. Brown, M.A.; McGarvey, B. R.; Ozarowski, A.; Tuck, D. G. Studies of organotin(IV)-orthoquinone systems. J. Organometal. Chem. 1998, 550 (1-2), 165-172.
31. Sisido, K.; Takeda, Y.; Kinugawa, Z. Direct synthesis of organtotin compounds. I. Di and tri-benzyltin chlorides. J. Am. Chem. Soc. 1960, 83, 538-541.
32. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenney, S.; Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 1990, 82 (13), 1107-1112.
33. Marchetti, F.; Pettinari, C.; Cingolani, A.; Pettinari, R.; Rossi, M.; Caruso, F. Organotin(IV) derivatives of novel β-diketones: Part V. Synthesis and characterization of di- and triorganotin(IV) derivatives of 4-acyl-5-pyrazolones modified in position 3 of the pyrazole. Crystal structure of (1,3-diphenyl-4-benzoyl-pyrazolon-5-ato)triphenyltin(IV). J. Organomet. Chem. 2002, 645 (1-2), 134-145.
34. Mahon, M. F.; Molloy, K. C.; Omotowa, B. A.; Mesubi, M. A. Organotin(IV) derivatives of acylpyrazol-5-ones. J. Organometal. Chem. 1996, 511, 227-237.
35. Whiffen, D. H. Vibrational frequencies and thermodynamic properties of fluoro-, chloro-, bromo-, and iodo-benzene. J. Chem. Soc. 1956, 1350-1355.
36. Ortiz, A.; Teruel, J. A.; Aranda, F. J. Effect of triorganotin compounds on membrane permeability. Biochim. Biophys. Acta. 2005, 1720 (1-2), 137-142.
37. Sherman, L. Relationship of cytotoxic groups in organotin molecules and the effectiveness of the compounds against leukaemia. Appl. Organometal. Chem. 1988, 2 (1), 65-72.
38. d'Arcy Doherty, M.; Rodgers, A.; Cohen, G. M. Mechanisms of toxicity of 2- and 5-hydroxy-1,4-naphthoquinone; absence of a role for redox cycling in the toxicity of 2-hydroxy-1,4-naphthoquinone to isolated hepatocytes. J. Appl. Toxicol. 1987, 7 (2), 123-129.
39. Babich, A.; Stern, A. In vitro cytotoxicities of 1,4-naphthoquinone and hydroxylated 1,4-naphthoquinones to replicating cells. J. Appl. Toxicol. 1993, 13(5), 353-358.
40. Cooke, G. M. Effect of organotins on human aromatase activity in vitro. Toxicol Lett. 2002, 126 (2), 121-130.
41. Osada, S.; Nishikawa, J.; Nakanishi, T.; Tanaka, K.; Nishihara, T. Some organotin compounds enhance histone acetyltransferase activity. Toxicol. Lett. 2005, 155 (2), 329-335.
42. Bolton, J. L.; Pisha, E.; Zhang, F.; Qiu, S. Role of quinoids in estrogen carcinogenesis. Chem. Res. Toxicol. 1998, 11 (10), 1113-1127.
43. Szorcsik, A.; Nagy, L.; Gajda-Schrantz, K. Structural studies on organotin (IV) complexes formed with ligands containing {S, N, O} donor atoms. J. Radioanal. Nucl. Chem. 2002, 252 (3), 523-530.
44. Nath, L. M.; Pokharia, S.; Yadav, R. Organotin(IV) complexes of amino acids and peptides. Coord. Chem. Rev. 2001, 215 (1), 99-149.
45. Gaussian 98; Revision, A.11. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Zakrzewski, V. G.; Montgomery, J. A.; Stratmann, R. E., Jr.; Burant, J. C.; Dapprich, S.; Millam, J. M.; Daniels, A. D.; Kudin, K. N.; Strain, M. C.; Farkas, O.; Tomasi, J.; Barone, V.; Cossi, M.; Cammi, R.; Mennucci, B.; Pomelli, C.; Adamo, C.; Clifford, S.; Ochterski, J.; Petersson, G. A.; Ayala, P. Y.; Cui, Q.; Morokuma, K.; Salvador, P.; Dannenberg, J. J.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Cioslowski, J.; Ortiz, J. V.; Baboul, A. G.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Gomperts, R.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M.W.; Johnson, B.; Chen, W.; Wong, M. W.; Andres, J. L.; Gonzalez, C.; Gordon, M.; Replogle, E. S.; Pople, J. A.; Gaussian, Inc.; Pittsburgh, PA, 2001, Gaussian 98 program.